IN THE NOW AND IN THE KNOW
verdemedica-2.jpg

LONGVIDA® EXHIBITS SIGNIFICANT IMPROVEMENTS TO NEUROPROTECTIVE BIOMARKERS

Longvida, Science, Functional Food & Beverage, Dietary Supplements, Animal Health

JUNE 2017 – Researchers at Central Michigan University have taken a closer look at Longvida® Optimized Curcumin. Previously, these researchers conducted amyloid binding work in vitro with promising results1. Recently published, in the International Journal of Alzheimer’s Disease, Maiti P et al have compared standard, unformulated curcumin more closely to Longvida with SLCP™ Technology.

These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.
Please note that the physiological activity of the ingredient(s) described herein is supported by the referenced clinical trial reports. Marketers of finished products containing the ingredient(s) described herein are responsible for determining whether claims made for such products are lawful and in compliance with the laws of the country in which they will market the products.
Verdure Sciences, Longvida (US Patent 9192644, EP Patent 1993365; additional patents pending), Bacognize, Calzbone, Pomella (US Patents 7638640, 7897791, and 7919636), Tinofend, and WokVel are registered trademarks of Verdure Sciences, Inc. Ashwamax, Bacoboost, Cinnagest, Factor21, Lutevida, Maplifa, Rejuna, Thymocid, Gingerize, VBATS, VerdeMedica, and SLP/SLCP are trademarks of Verdure Sciences, Inc. All Rights Reserved. © 2017 Verdure Sciences.
For our most current patent information, please visit: www.vs-corp.com/ip